ALUMIS INC. - COMMON STOCK

10,81

13-ноября-24 16:45:00

15 мин. задержка

Акции

-0,54

-4,76%

Сегодняшний диапазон

10,73 - 11,51

ISIN

N/A

Источник

NASDAQ

Alumis Reports Third Quarter 2024 Financial Results and Highlights Recent Achievements

13 ноя 2024 16:05:48 Источник Nasdaq GlobeNewswire
Alumis to Participate in Guggenheim's Inaugural Healthcare Innovation Conference

04 ноя 2024 08:00:00 Источник Nasdaq GlobeNewswire
Late-Breaking Data at EADV of ESK-001, an Oral TYK2 Inhibitor for the Treatment of Psoriasis, Demonstrate Significant Responses with Sustained Increases Over 28 Weeks in Phase 2 OLE Study

27 сен 2024 09:00:00 Источник Nasdaq GlobeNewswire
Alumis to Participate in Upcoming September Investor Conferences

03 сен 2024 16:29:30 Источник Nasdaq GlobeNewswire
Alumis Reports Second Quarter 2024 Financial Results and Highlights Recent Development and Corporate Achievements

13 авг 2024 16:05:27 Источник Nasdaq GlobeNewswire
Alumis Initiates ONWARD Phase 3 Clinical Program Evaluating ESK-001, an Oral TYK2 Inhibitor, in Moderate-to-Severe Plaque Psoriasis

29 июл 2024 08:00:00 Источник Nasdaq GlobeNewswire

<<
<
1
>

Принимаю NetDania's website uses cookies. By continuing browsing our website, you agree to our Правила в отношении Cookies, Политика конфиденциальности and Правила и условия.